113 related articles for article (PubMed ID: 21861445)
1. [Shifts in minimum inhibitory concentration of linezolid to Stapylococcus aureus strains isolated from 2007 to 2009].
Nakai T; Itoyama S; Kobayashi T; Hashimoto N; Kimura S
Kansenshogaku Zasshi; 2011 Jul; 85(4):386-8. PubMed ID: 21861445
[No Abstract] [Full Text] [Related]
2. EUCAST Technical Note on linezolid.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
[No Abstract] [Full Text] [Related]
3. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae.
Isaacson G; Aronoff SC
Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):647-51. PubMed ID: 18321598
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
[TBL] [Abstract][Full Text] [Related]
5. Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid.
Serisier DJ; Jones G; Carroll M
J Cyst Fibros; 2004 Mar; 3(1):61. PubMed ID: 15463889
[No Abstract] [Full Text] [Related]
6. A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency.
Taguchi K; Miyakawa T; Ohmura T; Horio M; Anraku Y; Okada T; Mizuta H; Saito H; Kawaguchi T
Scand J Infect Dis; 2013 Jan; 45(1):77-80. PubMed ID: 22992056
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
Jacqueline C; Caillon J; Grossi O; Le Mabecque V; Miegeville AF; Bugnon D; Batard E; Potel G
Antimicrob Agents Chemother; 2006 Jul; 50(7):2547-9. PubMed ID: 16801442
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: a case report.
Nathani N; Iles P; Elliott TS
J Infect; 2005 Nov; 51(4):e213-5. PubMed ID: 16291272
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).
Kaleem F; Usman J; Khalid A; Hassan A; Omair M
J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972
[TBL] [Abstract][Full Text] [Related]
10. Linezolid use in ventilator-associated pneumonia: look at the body weight of your patient!
De Pascale G; Fortuna S; Navarra P; Antonelli M
Minerva Anestesiol; 2012 Dec; 78(12):1418-9. PubMed ID: 22858883
[No Abstract] [Full Text] [Related]
11. Co-emergence of linezolid-resistant Staphylococcus aureus and Enterococcus faecium in a patient with methicillin-resistant S. aureus pneumonic sepsis.
An D; Lee MY; Jeong TD; Sung H; Kim MN; Hong SB
Diagn Microbiol Infect Dis; 2011 Feb; 69(2):232-3. PubMed ID: 21251573
[No Abstract] [Full Text] [Related]
12. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.
Balkhair A; Al Muharrmi Z; Darwish L; Farhan H; Sallam M
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e227-9. PubMed ID: 20005763
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory, anti-coagulant, anti-biotic?
Herwald H
Thromb Haemost; 2013 Apr; 109(4):582. PubMed ID: 23407848
[No Abstract] [Full Text] [Related]
14. [A case of refractory deep incisional surgical site infection due to methicillin-resistant Staphylococcus aureus (MRSA) and successfully treated with oral linezolid].
Matsumoto H; Kawabata R; Kishimoto T; Yamamoto E; Kimura Y; Imamura H; Yamamoto T; Takemoto H; Fukunaga M; Ohzato H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2441-3. PubMed ID: 23268104
[TBL] [Abstract][Full Text] [Related]
15. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
16. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun C; Rajan L; O'Neill E; Smyth EG
J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
[No Abstract] [Full Text] [Related]
17. Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid.
Yoshida K; Shoji H; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Fukuchi K; Adachi M; Niki Y
J Infect Chemother; 2009 Dec; 15(6):417-9. PubMed ID: 20012735
[TBL] [Abstract][Full Text] [Related]
18. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
19. Preseptal cellulitis caused by community acquired methicillin resistant Staphylococcus aureus (CAMRSA).
Charalampidou S; Connell P; Fennell J; Lynch M; Acheson R
Br J Ophthalmol; 2007 Dec; 91(12):1723-4. PubMed ID: 18024828
[No Abstract] [Full Text] [Related]
20. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
Kessler AT; Kourtis AP
Infection; 2007 Jun; 35(4):271-4. PubMed ID: 17646913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
